Sunesis Pharmaceuticals

Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecular therapeutics for oncology and other unmet medical needs. The company was founded by Jim Wells.[1][2]

Founded in 1998, Sunesis filed and completed an IPO in 2005. It is listed on NASDAQ as SNSS.

References

  1. ↑ http://findarticles.com/p/articles/mi_m4PRN/is_2003_July_29/ai_n27640059
  2. ↑ UCSF Helen Diller Family Comprehensive Cancer Center - People - James A. Wells, PhD


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.